The Biology of Time: Circadian Rhythm

How do animals, plants and even bacteria function without clocks and alarms? We now know this is down to the level of genetics, and humans too have circadian rhythms. But our modern lifetyle is disrupting this, with noticeable consequences. Is there room for innovation to fix the problem? Read here for more….

SIUOxford: Building Bridges in Biotech between UK-China (Part II)

For Part II of our event series on the UK-China ecosystem for science and technology development, our speakers presented the emerging area of contract research organizations and also highlighted academic initatives such as OSCAR, a university of Oxford led facility established in Suzhou, China.

SIUOxford: Biotech Booms in China - Innovation, Intellectual Property and Investment (Part I)

SIUOxford hosted an eye-opening two part event focused on the UK-China collaboration ecosystem for science and technology. In Part I, our three invited speakers addressed why there is a good match between the UK and China and presented two examples of start-ups that have benefitted from such collaboration. Read here for more..

The Power of Microbiota: Drivers of the Brain-Gut Axis in Psychiatry

We talked to Professor Ted Dinan from the University College Cork to learn more about his field of expertise- gut microbes and how they influence human brain function. Read here for more insights and his advice to medical students thinking about pursuing research.

Brave New Diagnostics: The Convergence of Genomic Sequencing and Machine Learning

Almost a century ago, the novel Brave New World portrayed a future in which technology and medicine are integral parts of our lives. How far have we come? How far will we go? This opinion article discusses our advancement in disease diagnostics, with special focus on the interlinks between genome sequencing and machine learning.

SIUOxford: Can Computers Replace Humans in Biological Research?

At our recent event, SIUOxford raised the question, ‘can computers replace humans in biological research?’ Three experts from academia and industry discussed computational contributions in fields such as disease diagnosis with big data, in silico drug discovery, organ simulation and biocatalyst discovery. Read here to find out more…

Local injection eliminates existing and prevents future cancer

Researchers at Stanford University injected two substances into cancerous tumours in mice to eliminate the injected tumour and others of the same cancer type in different parts of the body. The injection also stops cancer from spreading in the body and prevents future tumours that might arise due to genetic conditions. Read this review of the study to learn about the promising results and to understand the key concepts of immunotherapy used in this novel cancer treatment.

Expert Opinion from Prof Uwe Oelfke on MR-LINAC- A Pioneering Technology to Revolutionise Cancer Therapy

What is the state-of-the-art MR-LINAC and how is it a revolutionary device for radiotherapy treatment? Here, we interview Prof Uwe Oelfke, Head of the Joint Department of Physics at The Institute of Cancer Research (ICR) and The Royal Marsden. He shares his involvement with the MR-LINAC project and his hopes for the future of this technology. Read here for more…

Entrepreneurs of Immunotherapy: Q&A with Founders of Cell Medica and Autolus

Here we interview Gregg Sando, founder of Cell Medica and Dr. Martin Pule , founder of Autolus. Both recently spoke at the SIULondon event ‘Advances in Immunotherapy’. Read here to find out more about their career journeys into commercialization of immunotherapies and what they see for the future of this field.

SIULondon: Advances in Immunotherapy- Innovations from the frontline

The new frontier of the fight against diseases such as cancer is genetic engineering of immune system cells to be better equipped to target disregulated cells. SIULondon recently hosted speakers from Cell Medica, Autolus, GSK and Cell & Gene Therapy Catapult to cover research advances in the field of immunotherapy, hurdles to bringing this treatment to the bedside and regulatory challenges. Check out the event summary here…

The story of Big Pharma in India- Do patients or patents win?

Does the justice system oversee big pharma and its drug patent culture? Who does this culture benefit the most- pharma or the patients? Here is a case study in India where the generic drug manufacturers won against a major pharma company, with many seeing this as a victory for patients in terms of drug afforadability. Read on this opinion piece here…

SIUKatowice: The Power of Poop with Prof. Ted Dinan

SIUKatowice recently hosted Prof. Ted Dinan, currently the Professor of Psychiatry and a Principal Investigator in the Alimentary Pharmabiotic Centre at University College Cork. As an expert in intestinal bacteria, he presented recent findings in the field of psychobiotics- illustrating a pronouced connection between gut microbiota and host mental health. Read here to learn more…

SIUOxford Career Session: The Path to Industry

SIUOxford recently hosted their first event as part of SIU Career Sessions- a new series addressing different career paths for scientists, e.g. in industry, start-ups, and consulting. We welcomed Dr. Jan Nygaard Jensen from NovoNordisk and Dr. Ita O’Kelly from Immunocore. Read here to learn their invaluable advice for early career researchers thinking about transitioning to industry.

Translating Cell and Gene Therapy: Interviews with Dr. Bo Kara and Dr. Jacqueline Barry

Ahead of the SIULondon ‘Advances in Immunotherapy’ event, we interviewed Dr. Bo Kara from GlaxoSmithKline (GSK) and Dr. Jacqueline Barry from Cell and Gene Therapy (CGT) Catapult. Both experts share their role in supporting the cell and gene therapy field and give their insights on industry science and more… Read on here.